Mithun Abraham Prakash

Assistant Professor, Clinical Haematology, CMC Vellore

[Vikram Mathews @MathewsVikram]

https://t.co/T9IsXnoSWC
July 29th to 31st, 2026
Comprehensive review of Hematology
Department of Hematology and
Department of Transfusion Medicine & Immunohematology
Christian Medical College, Vellore
@OffCMCVellore @cmchaematology @HCC_HemeCancer

[Nadim Mahmud, MD, PhD, MBA @Nadim_M_Chicago]

I had the opportunity to visit CMC Vellore and its BMT program last year. It is an excellent institution with a highly dedicated team actively engaged in cell therapy….@ISCTglobal

[Pramesh CS @cspramesh]

Grateful to our Paediatric Oncology team for making this happen: one of our children with an incurable cancer had two last wishes: meet MS Dhoni, and ride a @Lamborghini. Today, we could make one of these happen. If any of you have contacts with MSD, pls connect us.

[Vikram Mathews @MathewsVikram]

Happy to share a recent publication:
https://t.co/LUlPwn0tMS

[Pawan Khera 🇮🇳 ಪವನ್ ಖೇರಾ @Pawankhera]

To steal the people’s mandate in Haryana, the BJP - with the complicity of the Election Commission of India - carried out a systematic electoral fraud:

1. Inserted a “Brazilian model” 220 times into the voter list of 10 booths.
2. ⁠Allowed BJP leaders and their families from Uttar Pradesh to vote in Haryana.
3. ⁠Blurred voter photographs on electoral rolls to make genuine voters unrecognisable.
4. ⁠Deleted 3.5 lakh voters who had voted in the 2024 Lok Sabha elections, just before the Vidhan Sabha polls.
5. ⁠Registered thousands of ghost voters under a mysterious address - House No. 0.

In an election where the victory margin between the BJP and the INC was a mere 22,779 votes, a staggering 25,41,144 votes were stolen through these methods. It’s no longer a question - those running the country aren’t winning elections, they’re robbing democracy in broad daylight.

[Hematology Cancer Consortium @HCC_HemeCancer]

Thank you to everyone who made the 5th #HCCAnnualMeeting (with RESMO at NCI–AIIMS Jhajjar) such a success!🙏
3 days. Countless insights. One shared mission — advancing patient-centered hematologic care.
Join the HCC community 👇
🔗 https://t.co/GDaSTdFw0X
https://t.co/O0nL8Eiqxf

[Arun Kumar Arunachalam @DrArunCMC]

Low-dose Nivolumab and Lenalidomide in Relapsed/Refractory Hodgkin Lym... https://t.co/RJTdusAy3Z. @MathewsVikram @udaypkulkarni @drdatari

[Chepsy C Philip @chepsyphilip]

Cure for myeloma? Who other than the brilliant ⁦@myelomaMD⁩ deliberating at the ⁦@HCC_HemeCancer⁩ annual conference ⁦@DrPMPGI⁩ ⁦@DrNikitaMehra⁩ ⁦@DrGPrakash⁩ ⁦@MathewsVikram⁩

[Hematology Cancer Consortium @HCC_HemeCancer]

🚀Day 1 of the 5th #HCCAnnualMeeting is off to a POWERFUL start!
3 brilliant talks kicking off the science

[Nikita Mehra @DrNikitaMehra]

Fantastic brief study presentations this morning on Inotuzumab ozogamicin in R/R ALL, R-CHOP vs. R-DA-EPOCH in DE lymphomas, and outpatient intensive chemo administration for AML.
@mithunap11

[Pramesh CS @cspramesh]

Don't miss this. The Ida Scudder oration delivered by Dr Ravi Kannan @DrRRaviKannan @CCHRCCancerCare
One of my all-time heroes. True legend in cancer control. And generally great guy.

24th September at 6 30 PM IST

https://t.co/yBad9aBcX6

[akhilrk1989 @akhilrk1989]

Join us to understand more about the optimal use of gilteritinib-based therapy for relapsed/refractory FLT3-positive AML. https://t.co/CP0IUUKcAU

📅 Sep 19, 2025, 9 AM ET

🔗 Register: https://t.co/HSooJuYRsQ

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

🎉💥 Brand new publication from our group at the @pmcancercentre 💪🏽

Out now in the British Journal of Haematology @BrJHaem 🙌🏽

We report our decade long experience using a combination of PTCy and ATG for GvHD prophylaxis in the MUD setting!

[akhilrk1989 @akhilrk1989]

Published in @BloodCancerJnl!

Our @pmcancercentre study on 68 R/R FLT3m AML patients treated with gilteritinib-based therapy is out!

Watch for the triple-mutated cohort outcomes!

https://t.co/CP0IUUKcAU

[Mithun Abraham Prakash @mithunap11]

@DRitudhwaj I haven’t studied in Sion but we have three faculty here in Haematology at CMC( two of whom were my batchmates during DM) . I can vouch for their clinical accumen and work ethic. And they all have very fond memories of their time at Sion

[Vikram Mathews @MathewsVikram]

PGCME registration is still open. Spot registration is also available, and a spill-over hall is available to accommodate additional attendees.

[Ajay Kamath @ajay43]

The accusation is against the EC. The defence is coming entirely from the BJP.
The fault lines are fairly clear….

[Sanjay Jha @JhaSanjay]

Dear #ElectionCommission

#RahulGandhi as Leader of Opposition has the support of 42% of INDIA Alliance voters.

Mr Modi as Prime Minister has the backing of 44% of NDA voters.

There is just a 2% difference, kindly note. The LoP deserves respect, not your contumacious attitude: Take an oath, give an affidavit etc. What sense does that even make, gentlemen????

Instead of dodging Mr Gandhi’s expose on alleged electoral malpractices or fraud, you need to address them, point by point. That is the public expectation. It is normal.

This is not about the Congress or the opposition. This is about each one of us. This is about our country. And we all have a right to seek a thorough investigation into the shocking discrepancies pointed out.

Above everything else, you should be in a hurry yourself to come clean on the charges made. It is strange that you are giving the perception of sandbagging the process itself. And if there is any political pressure on you, you should speak out.

The ball is in your court.

#VoteChori @ECISVEEP @INCIndia @Jairam_Ramesh @RahulGandhi

[Mohammed Zubair @zoo_bear]

The Election Commission today removed the digital machine-readable Bihar draft voter lists from its website which were uploaded on Aug 1. They have been replaced with their scanned, non-machine-readable versions that makes scrutiny harder.
https://t.co/7bNwXafUkr

[Vikram Mathews @MathewsVikram]

Who Should Attend?
• Hematologists/oncologists/Hematopathologists
• PG's : Internal Medicine/Pediatrics/Pathology/Basic Scientist with interest in hematological malignancies
• Industry partners
• Nurses and allied health professionals
• Patient navigators and advocates